Are bacterial meningitis and hepatitis A reportable diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, both bacterial meningitis and hepatitis A are reportable diseases to public health authorities.

Both bacterial meningitis and hepatitis A must be reported to the CDC's National Notifiable Diseases Surveillance System, as they are nationally notifiable diseases that require public health tracking for outbreak detection and prevention. 1

Bacterial Meningitis Reporting Requirements

Bacterial meningitis is reportable with specific requirements based on the causative organism 1:

  • Specific organism reporting: Cases caused by Haemophilus influenzae, Neisseria meningitidis, group A Streptococcus, and Listeria monocytogenes must be reported under disease codes specific to these organisms
  • "Bacterial meningitis, other": Only cases caused by organisms other than those listed above should be reported under this general category
  • Case definition: A confirmed case requires either laboratory confirmation (isolation of bacteria from CSF) or a clinically compatible case with positive blood culture

Reporting Timeliness

The median time for bacterial meningitis reporting to national surveillance is approximately 20 days 2, though this varies by state. Given that bacterial meningitis can progress rapidly to shock and death 1, prompt local reporting is critical even though national reporting may take longer.

Hepatitis A Reporting Requirements

Hepatitis A is a nationally notifiable disease that requires reporting to public health authorities. The median reporting time to national surveillance is approximately 33 days 2, making it one of the slower-reported notifiable diseases, though local reporting requirements are typically more immediate.

Clinical Pitfall

Common mistake: Assuming only meningococcal meningitis is reportable. In reality, all bacterial meningitis cases must be reported, though the specific reporting category depends on the causative organism 1. Failure to report can compromise outbreak detection, particularly in high-risk settings like sporting events where attendees disperse to multiple locations within the incubation period 3.

Related Questions

Which of the following statements about meningitis is false? A) A petechial rash may be observed in cases of meningococcal meningitis. B) Diagnosis is established via lumbar puncture and cerebrospinal fluid culture. C) Kernig's and Brudzinski's signs are characteristic clinical findings. D) There are no vaccines available for the prevention of meningitis. E) Headache, fever, and photophobia are frequently observed clinical signs.
What chemoprophylaxis regimen is appropriate for the asymptomatic household contacts of a pediatric patient diagnosed with meningococcal meningitis?
What cerebrospinal fluid findings differentiate bacterial meningitis from viral meningitis?
What empiric intravenous antibiotics are recommended for bacterial meningitis presenting with a bulging membrane (e.g., bulging fontanelle)?
How can transmission of meningococcal meningitis from a child to household contacts be prevented?
What is the term for a mild lumbar disc bulge at L4‑S5 causing moderate neuroforaminal stenosis?
I accidentally ingested chewing gum. Do I need any medical treatment?
What are the key considerations when verifying a morphine infusion (drip) for a patient?
What is the recommended intravenous immunoglobulin (IVIG) dosing regimen for Kawasaki disease?
What are the Indian guidelines for intravenous immunoglobulin (IVIG) and aspirin dosing in children with Kawasaki disease?
In a patient with vasculitis secondary to long‑standing rheumatoid arthritis who is receiving pulse steroids and cyclophosphamide, should I still provide cotrimoxazole (trimethoprim‑sulfamethoxazole) prophylaxis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.